Huapont Life Sciences Co., Ltd. (002004.SZ)
CNY 3.9
(3.17%)
CNY 3.9
(3.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 926.51 Million CNY | -65.09% |
| 2022 | 2.65 Billion CNY | 40.13% |
| 2021 | 1.89 Billion CNY | 8.83% |
| 2020 | 1.74 Billion CNY | -5.03% |
| 2019 | 1.83 Billion CNY | 3.37% |
| 2018 | 1.77 Billion CNY | 55.61% |
| 2017 | 1.13 Billion CNY | 73.18% |
| 2016 | 657.78 Million CNY | -12.62% |
| 2015 | 752.76 Million CNY | 56.36% |
| 2014 | 481.41 Million CNY | 25.09% |
| 2013 | 384.84 Million CNY | -9.63% |
| 2012 | 425.87 Million CNY | 39.12% |
| 2011 | 306.12 Million CNY | 104.28% |
| 2010 | 149.85 Million CNY | 9.07% |
| 2009 | 137.39 Million CNY | 37.96% |
| 2008 | 99.59 Million CNY | -59.64% |
| 2007 | 246.79 Million CNY | 252.4% |
| 2006 | 70.03 Million CNY | 10.79% |
| 2005 | 63.21 Million CNY | 7.27% |
| 2004 | 58.92 Million CNY | 24.43% |
| 2003 | 47.35 Million CNY | 7.19% |
| 2002 | 44.18 Million CNY | 22.18% |
| 2001 | 36.16 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 221.74 Million CNY | -19.82% |
| 2024 Q1 | 285.77 Million CNY | 248.79% |
| 2024 Q2 | 276.56 Million CNY | -3.22% |
| 2023 FY | 926.51 Million CNY | -65.09% |
| 2023 Q4 | -192.06 Million CNY | -162.19% |
| 2023 Q3 | 308.82 Million CNY | -29.28% |
| 2023 Q2 | 436.69 Million CNY | 17.06% |
| 2023 Q1 | 373.05 Million CNY | 315.63% |
| 2022 FY | 2.65 Billion CNY | 40.13% |
| 2022 Q1 | 644.5 Million CNY | -18.12% |
| 2022 Q2 | 813.94 Million CNY | 26.29% |
| 2022 Q3 | 817.31 Million CNY | 0.41% |
| 2022 Q4 | -173 Million CNY | -121.17% |
| 2021 Q3 | 288.73 Million CNY | -27.48% |
| 2021 Q4 | 787.14 Million CNY | 172.62% |
| 2021 Q2 | 398.13 Million CNY | 68.14% |
| 2021 Q1 | 236.78 Million CNY | -12.98% |
| 2021 FY | 1.89 Billion CNY | 8.83% |
| 2020 Q1 | 146.42 Million CNY | -30.87% |
| 2020 FY | 1.74 Billion CNY | -5.03% |
| 2020 Q3 | 380.25 Million CNY | -4.0% |
| 2020 Q4 | 272.1 Million CNY | -28.44% |
| 2020 Q2 | 396.08 Million CNY | 170.5% |
| 2019 Q3 | 412.1 Million CNY | 23.46% |
| 2019 FY | 1.83 Billion CNY | 3.37% |
| 2019 Q1 | 198.24 Million CNY | 32.49% |
| 2019 Q2 | 333.79 Million CNY | 68.37% |
| 2019 Q4 | 211.82 Million CNY | -48.6% |
| 2018 Q2 | 382.08 Million CNY | 84.54% |
| 2018 FY | 1.77 Billion CNY | 55.61% |
| 2018 Q4 | 149.63 Million CNY | -57.52% |
| 2018 Q3 | 352.2 Million CNY | -7.82% |
| 2018 Q1 | 207.04 Million CNY | -16.45% |
| 2017 Q1 | 183.62 Million CNY | 315.07% |
| 2017 FY | 1.13 Billion CNY | 73.18% |
| 2017 Q4 | 247.81 Million CNY | 383.23% |
| 2017 Q2 | 227.11 Million CNY | 23.68% |
| 2017 Q3 | 51.28 Million CNY | -77.42% |
| 2016 Q2 | 302.11 Million CNY | 43.71% |
| 2016 FY | 657.78 Million CNY | -12.62% |
| 2016 Q4 | -85.37 Million CNY | -136.99% |
| 2016 Q3 | 230.82 Million CNY | -23.6% |
| 2016 Q1 | 210.22 Million CNY | 320.85% |
| 2015 FY | 752.76 Million CNY | 56.36% |
| 2015 Q4 | 49.95 Million CNY | -77.82% |
| 2015 Q3 | 225.22 Million CNY | -11.48% |
| 2015 Q2 | 254.43 Million CNY | 14.03% |
| 2015 Q1 | 223.14 Million CNY | 650.85% |
| 2014 Q4 | 29.71 Million CNY | -82.12% |
| 2014 Q1 | 95.79 Million CNY | 39.76% |
| 2014 FY | 481.41 Million CNY | 25.09% |
| 2014 Q2 | 189.7 Million CNY | 98.03% |
| 2014 Q3 | 166.19 Million CNY | -12.4% |
| 2013 Q3 | 124.86 Million CNY | 8.42% |
| 2013 Q2 | 115.16 Million CNY | 50.99% |
| 2013 Q1 | 76.27 Million CNY | 214.39% |
| 2013 Q4 | 68.54 Million CNY | -45.11% |
| 2013 FY | 384.84 Million CNY | -9.63% |
| 2012 Q4 | 24.26 Million CNY | -77.93% |
| 2012 Q3 | 109.93 Million CNY | -50.74% |
| 2012 Q2 | 223.16 Million CNY | 225.72% |
| 2012 Q1 | 68.51 Million CNY | -65.0% |
| 2012 FY | 425.87 Million CNY | 39.12% |
| 2011 Q4 | 195.77 Million CNY | 330.59% |
| 2011 Q1 | 22.55 Million CNY | -59.81% |
| 2011 Q2 | 42.33 Million CNY | 87.7% |
| 2011 FY | 306.12 Million CNY | 104.28% |
| 2011 Q3 | 45.46 Million CNY | 7.4% |
| 2010 Q1 | 17.53 Million CNY | -33.2% |
| 2010 Q2 | 30.41 Million CNY | 73.42% |
| 2010 Q3 | 45.78 Million CNY | 50.52% |
| 2010 Q4 | 56.12 Million CNY | 22.59% |
| 2010 FY | 149.85 Million CNY | 9.07% |
| 2009 Q4 | 26.25 Million CNY | -22.17% |
| 2009 Q3 | 33.73 Million CNY | -25.82% |
| 2009 Q2 | 45.47 Million CNY | 42.45% |
| 2009 Q1 | 31.92 Million CNY | -14.14% |
| 2009 FY | 137.39 Million CNY | 37.96% |
| 2008 Q3 | 28.7 Million CNY | 43.2% |
| 2008 Q2 | 20.04 Million CNY | 46.68% |
| 2008 Q1 | 13.66 Million CNY | -84.92% |
| 2008 Q4 | 37.18 Million CNY | 29.56% |
| 2008 FY | 99.59 Million CNY | -59.64% |
| 2007 Q1 | 52.61 Million CNY | 155.53% |
| 2007 FY | 246.79 Million CNY | 252.4% |
| 2007 Q4 | 90.61 Million CNY | 41.36% |
| 2007 Q3 | 64.09 Million CNY | 62.42% |
| 2007 Q2 | 39.46 Million CNY | -25.0% |
| 2006 Q2 | 8.53 Million CNY | -12.88% |
| 2006 Q1 | 9.79 Million CNY | -27.38% |
| 2006 FY | 70.03 Million CNY | 10.79% |
| 2006 Q4 | 20.59 Million CNY | -33.79% |
| 2006 Q3 | 31.1 Million CNY | 264.31% |
| 2005 Q1 | 7.55 Million CNY | -61.32% |
| 2005 Q4 | 13.49 Million CNY | -51.22% |
| 2005 FY | 63.21 Million CNY | 7.27% |
| 2005 Q3 | 27.66 Million CNY | 90.74% |
| 2005 Q2 | 14.5 Million CNY | 92.04% |
| 2004 Q4 | 19.52 Million CNY | 48.46% |
| 2004 Q2 | 18.07 Million CNY | 121.2% |
| 2004 FY | 58.92 Million CNY | 24.43% |
| 2004 Q1 | 8.17 Million CNY | -23.77% |
| 2004 Q3 | 13.15 Million CNY | -27.25% |
| 2003 Q4 | 10.72 Million CNY | -15.42% |
| 2003 FY | 47.35 Million CNY | 7.19% |
| 2003 Q3 | 12.67 Million CNY | 0.0% |
| 2002 FY | 44.18 Million CNY | 22.18% |
| 2001 FY | 36.16 Million CNY | 0.0% |